| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3015256 | Revista Española de Cardiología | 2009 | 9 Pages |
Abstract
In patients with resistant hypertension, the addition of either spironolactone or doxazosin resulted in a significant decrease in BP, though the decrease appeared to be greater with spironolactone. The presence of diabetes complicated BP control.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Enrique Rodilla, José A. Costa, Francisco Pérez-Lahiguera, Emilio Baldó, Carmen González, José M. Pascual,